Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADVANCE-3: Apixaban vs Enoxaparin in Hip Replacement
NCT00423319Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Mar 2007
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 21
01
Overview
A Phase 3 trial of apixaban in venous thromboembolism (VTE), sponsored by Bristol Myers Squibb. Started Mar 2007; status: completed.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00423319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00423319.